Abstract
Background
Roux-en-Y gastric bypass (RYGB) interferes considerably with the anatomy and physiology of the gastrointestinal tract. The study of intestinal permeability can provide important information regarding changes in the structure and function of the mucosal barrier after the procedure.
Methods
The urinary excretion rates of lactulose and mannitol after oral intake of both substances were evaluated. We also evaluated the lactulose/mannitol excretion ratio. Tests were performed during the preoperative period (T0), at the first postoperative month (T1), and at the sixth postoperative month (T6).
Results
The study included 16 morbidly obese patients. The excretion rate of mannitol was significantly lower at T1 compared with T0 and T6 (p = 0.003). There was no significant difference in the excretion rates of lactulose or in the lactulose/mannitol ratio during the three periods. Six patients (37.5 %) exhibited a considerable increase in the excretion rate of lactulose at T6 (4–73 times higher than the preoperative value), accompanied by proportional variations in the lactulose/mannitol ratio.
Conclusions
The significant increase in mannitol excretion rate from T1 to T6 most likely reflects the occurrence of intestinal adaptation (mucosal hyperplasia), which would tend to minimize the malabsorption of macronutrients. A subgroup of patients who undergo RYGB exhibit pronounced increase in their intestinal permeability (assessed by the lactulose/mannitol ratio and the lactulose excretion rate) at T6.
Similar content being viewed by others
References
Lonut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263–82.
Flancbaum L. Mechanisms of weight loss after bariatric surgery. J Laparoendosc Adv Surg Tech A. 2003;13(4):215–20. PMID: 14561249.
Diniz MFHS, Passos VMA, Diniz MTC. Gut-brain communication: how does it stand after bariatric surgery? Curr Opin Clin Nutr Metab Care. 2006;9(5):629–3.
Vilela EG, Torres HO, Ferrari ML, et al. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008;41(12):1105–9. PMID: 19148373.
Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol. 2008;43(7):842–8. PMID: 18584523.
Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clinical science. 1992;82(5):471–88. PMID: 1317756.
Scaldaferri F, Pizzoferrato M, Gerardi V, et al. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol. 2012;46(Suppl):S12–7. PMID: 22955350.
Camilleri M, Madsen K, Spiller R, et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24(6):503–12. PMID: 22583600.
Gaggiotti G, Catassi C, Sgattoni C, et al. Modifications of intestinal permeability test induced by biliopancreatic diversion: preliminary results. Obes Surg. 1995;5(4):424–6. PMID: 10733839.
Sigalet DL, Martin GR, Poole A. Differential sugar absorption as a marker for adaptation in short bowel syndrome. J Pediatr Surg. 2000;35(5):661–4.
Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92(4):704–13. PMID: 20739420.
Seva-Pereira G, Lopes LR, Brandalise NA, et al. Fat absorption after total gastrectomy in rats submitted to Roux-en-Y or Rosanov-like double-transit technique. Acta Cir Bras. 2006;21(6):380–4. PMID: 17160249.
Ponsky TA, Brody F, Pucci E. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. 2005;201(1):125–31. PMID: 15978453.
Leth RD, Abrahamsson H, Kilander A, et al. Malabsorption of fat after partial gastric resection. A study of pathophysiologic mechanisms. Eur J Surg Acta chir. 1991;157(3):205–8.
Hess DS. Limb measurements in duodenal switch. Obes Surg. 2003;13(6):966. PMID: 14738693.
Savassi-Rocha AL, Diniz MT, Savassi-Rocha PR, et al. Influence of jejunoileal and common limb length on weight loss following Roux-en-Y gastric bypass. Obes Surg. 2008;18(11):1364–8. PMID: 18459021.
Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients—an evidence-based review. Obes Surg. 2011;21(1):119–24. PMID: 20680504.
Orci L, Chilcott M, Huber O. Short versus long Roux-limb length in Roux-en-Y gastric bypass surgery for the treatment of morbid and super obesity: a systematic review of the literature. Obes Surg. 2011;21(6):797–804. PMID: 21479976.
Cisler JJ, Buchman AL. Intestinal adaptation in short bowel syndrome. J Investig Med. 2005;53(8):402–13. PMID: 16354579.
Fenyo G. Morphological changes of the adapting small intestine deprived of gastric, duodenal, biliary and pancreatic secretions in the rat. Eur Surg Res. 1977;9(2):122–30. PMID: 856595.
Taqi E, Wallace LE, de Heuvel E, et al. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg. 2010;45(5):987–95. PMID: 20438940.
Albert V, Young GP, Morton CL, et al. Systemic factors are trophic in bypassed rat small intestine in the absence of luminal contents. Gut. 1990;31(3):311–6. PMID: 2323595.
Miedema BW, Kelly KA, Camilleri M, et al. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology. 1992;103(4):1133–43. PMID: 1397870.
Seyfried F, Lannoo M, Gsell W, et al. Roux-en-Y gastric bypass in mice—surgical technique and characterisation. Obes Surg. 2012;22(7):1117–25. PMID: 22527601.
Suzuki S, Ramos EJ, Gonçalves CG, et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery. 2005;138(2):283–90.
Wang G, Agenor K, Pizot J, et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (BGP). Obes Surg. 2012;22:1263–7.
Ardila-Hani A, Soffer EE. Review article: the impact of bariatric surgery on gastrointestinal motility. Aliment Pharmacol Ther. 2011;34(8):825–31. PMID: 21854401.
Zhang YM, Liu XL, Xue DB, et al. Myoelectric activity and motility of the Roux limb after cut or uncut Roux-en-Y gastrojejunostomy. World J Gastroenterol. 2006;12(47):7699–704. PMID: 17171803.
Spak E, Bjorklund P, Helander HF, et al. Changes in the mucosa of the Roux-limb after gastric bypass surgery. Histopathology. 2010;57(5):680–8. PMID: 21054493.
Benjamin MA, McKay DM, Yang PC, et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000;47:112–9.
Moran GW, O'Neill C, McLaughlin JT. GLP-2 enhances barrier formation and attenuates TNFalpha-induced changes in a Caco-2 cell model of the intestinal barrier. Regul Pept. 2012;178(1–3):95–101. PMID: 22809889.
Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2 driven improvement of gut permeability. Gut. 2009;58:1091–103.
leRoux CW, Borg C, Wallis K, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg. 2010;252(1):50–6.
Ljungmann K, Hartmann B, Kissmeyer-Nielsen P, et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G779–85. PMID: 11518690.
Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012;5(3):159–71. PMID: 22570676.
Sigalet DL, Lam V, Boctor D. The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function. Semin Pediatr Surg. 2010;19(1):44–9. PMID: 20123273.
Sinclair EM, Drucker DJ. Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology (Bethesda). 2005;20:357–65. PMID: 16174875.
Moreira AP, Texeira TF, Ferreira AB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxemia. Br J Nutr. 2012;108(5):801–9.
Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN Journal of Parenteral and Enteral Nutrition. 2011;35(5 Suppl):14S–20S. PMID: 21807932.
Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22:950–55.
Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2012;151(4):587–93. PMID: 22088821.
Moschen AR, Molnar C, Geiger S, et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut. 2010;59(9):1259–64. PMID: 20660075.
Dalmas E, Rouault C, Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94(2):450–8. PMID: 21677057.
Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alfa receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67(5):679–86.
Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618–24. PMID: 21546319.
Morinigo R, Casamitjana R, Delgado S, et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care. 2007;30(7):1906–8. PMID: 17468354.
Joao Cabrera E, Valezi AC, Delfino VD, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20(1):42–9. PMID: 19826889.
Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084–96.
Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198–204. PMID: 19381735.
Machado JD, Campos CS, Lopes Dah Silva C, et al. Intestinal bacterial overgrowth after Roux-en-Y gastric bypass. Obes Surg. 2008;18(1):139–43. PMID: 18080824.
Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28(5):293–8. PMID: 19083422.
Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049–57. PMID: 20876719.
Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17(6):752–8. PMID: 17879574.
Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk. Gut. 2011;60(9):1214–23. PMID: 21572120.
Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9(10):590–8. PMID: 22926153.
Riordan SM, McIver CJ, Wakefield D, et al. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31(10):977–84. PMID: 8898418.
Morris TH, Sorensen SH, Turkington J, et al. Diarrhoea and increased intestinal permeability in laboratory beagles associated with proximal small intestinal bacterial overgrowth. Lab Anim. 1994;28(4):313–9. PMID: 7830370.
Batt RM, Hall EJ, McLean L, et al. Small intestinal bacterial overgrowth and enhanced intestinal permeability in healthy beagles. Am J Vet Res. 1992;53(10):1935–40. PMID: 1456544.
Rutgers HC, Batt RM, Proud FJ, et al. Intestinal permeability and function in dogs with small intestinal bacterial overgrowth. J Small Anim Pract. 1996;37(9):428–34. PMID: 8887203.
Lauritano EC, Valenza V, Sparano L, et al. Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010;45(9):1131–2. PMID: 20443749.
Riordan SM, McIver CJ, Williams R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol. 1998;93(2):234–7. PMID: 9468250.
Riordan SM, McIver CJ, Thomas DH, et al. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997;32(6):556–63. PMID: 9200287.
Drenick EJ, Roslyn JJ. Cure of arthritis-dermatitis syndrome due to intestinal bypass by resection of nonfunctional segment of blind loop. Dig Dis Sci. 1990;35(5):656–60.
Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol. 2011;52(1):e5–7. PMID: 21332683.
Conflicts of interest
Alexandre Lages Savassi-Rocha, Marco Túlio Costa Diniz, Eduardo Garcia Vilela, Maria de Fátima Haueisen Sander Diniz, Soraya Rodrigues de Almeida Sanches, Aloísio Sales da Cunha, Maria de Lourdes de Abreu Ferrari, Henrique Oswaldo da Gama Torres, Bruno Antonio Maciente, Gabriela Santana Ataliba, Paloma Maciel Araújo, Taciana Bretas Guerra, and Inara Kellen Fonseca Balbino declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Savassi-Rocha, A.L., Diniz, M.T.C., Vilela, E.G. et al. Changes in Intestinal Permeability after Roux-en-Y Gastric Bypass. OBES SURG 24, 184–190 (2014). https://doi.org/10.1007/s11695-013-1084-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-1084-y